Â鶹´«Ã½

St. Jude Children’s Research Hospital physicians and scientists are onsite at this year’s American Society of Clinical Oncology annual meeting and available to discuss pediatric oncology research and treatment.

In addition, Leslie Robison, Ph.D., received the 2014 Pediatric Oncology Award from ASCO. The award recognizes Dr. Robison’s more than 30-year career of advancing childhood cancer survivorship research. (Photos available.) St. Jude physicians and scientists are available for interview.• Leslie L. Robinson, Ph.D., is available to discuss the epidemiology and etiology of childhood cancer, cancer survivorship and how lessons from past treatment are being used to guide tomorrow’s treatments. At St. Jude, he is chair of the Epidemiology and Cancer Control Department. • Melissa Hudson, M.D., is available to discuss fertility and other survivorship health issues. She is director of the Cancer Survivorship Division and co-leader of the Cancer Prevention and Control Program at St. Jude. • Daniel Green, M.D., is available to discuss late effects of childhood cancer treatment, particularly fertility and pregnancy outcome, cardiac disease and second malignant tumors. At St. Jude, he is a member of the Department of Epidemiology and Cancer Control.• Greg Armstrong, M.D., is available to discuss memory issues, second cancers, heart disease and other late effects associated with childhood cancer treatment. His work includes evidence that certain childhood cancer survivors show signs of brain changes and memory problems comparable to people decades older. At St. Jude, he is an associate member in the Department of Epidemiology and Cancer Control.• Kirsten Ness, Ph.D., is available to discuss premature aging and other physical effects associated with childhood cancer treatment. Her work has shown childhood cancer survivors are more likely than their peers to be frail at a younger age than the general population. The NIH recently awarded a five-year grant for her to continue this work to better understanding why survivors experience these physical late effects. At St. Jude, she is an assistant member in the Department of Epidemiology and Cancer Control.• Daniel Mulrooney, M.D., is available to discuss the transition of care between pediatric to adult medicine related to childhood cancer, adolescent and young adult oncology as well as late effects, including cardiovascular issues, that childhood cancer survivors experience. At St. Jude, he is the deputy director of the After Completion of Therapy Clinic. • Alberto Pappo, M.D., is available to discuss pediatric melanoma and targeted therapies for young melanoma patients. At St. Jude, he is co-leader of the Developmental Biology and Solid Tumor Program, and a member in its Oncology department.